Introduction
Pharmacokinetics is the science of the kinetics of drug absorption, distribution, and elimination (i.e., metabolism and excretion). Kinetics is the study of the rate of a process and the factors affecting on it. The rate of a process is the change in velocity or speed with (in relation to) time.
Usually, pharmacokinetics study involves considering both experimental and theoretical approaches. The former involves development of biologic sampling techniques, analytical methods for drugs and their metabolites measurement, and procedures that help in data collection and handling, while the latter approach of pharmacokinetics involves development of pharmacokinetic models that facilitate prediction of drug disposition after drug administration [1] .
For the processes of drug absorption, distribution, and elimination, there is a rate that governs each process. The rate is the change in concentration with time and is given by ± dC/dt.
According to the law of mass action, the rate of a chemical reaction (or a kinetic process) is proportional to the products of the molar concentration of the reactants each raised to a power equal to the number of molecules of substances undergoing reaction (process).
• The rate expression for zero order reaction: Mostly, the pharmacokinetic processes (absorption, distribution, and elimination) are firstorder, although zero-order also accounts for some processes such as the process of absorption, which is first-order for the passive transport mechanism and zero-order for the carriermediated transport (1) .
It must be mentioned that drug kinetics after distribution is characterized by the first-order rate constant.
A compartment in pharmacokinetics is an entity that can be described by a definite volume and a concentration of a drug contained in that volume, which may be:
Central Compartment
The central compartment includes blood and the highly perfused organs and tissues such as heart, brain, lungs, liver, and kidney. In these organs, the administered drug usually equilibrates rapidly.
Peripheral Compartment(s)
This compartment(s) include(s) those organs that are less well-perfused such as adipose and skeletal muscle, and therefore the administered drug will equilibrate more slowly in these organs. The duration of the drug effect at the target tissue will often be affected by the redistribution from one compartment to another. For example, the general anesthetic drug, thiopental, which is a highly lipid-soluble agent, induces anesthesia within seconds owing to drug rapid equilibration between blood and brain. The duration of anesthesia is short due to drug redistribution into adipose tissue, which can act as a storage site, or drug reservoir, although thiopental is slowly metabolized.
Special Compartments
Drug access to some body parts such as the cerebrospinal fluid (CSF) and central nervous system (CNS) is controlled by the structure of the CNS blood capillaries and the outermost layer of the neural tissue, i.e., pericapillary glial cells (the choroid plexus is an exception). Also, some drugs have relatively poor access to pericardial fluid, bronchial secretions, and fluid in the middle ear, thus making the treatment of infections in these regions difficult. These special compartments deserve mention as a separate category.
A pharmacokinetic model is a model devised to simulate the rate process of drug absorption, distribution, metabolism, and elimination with little physiological detail.
During development and formulation of pharmaceutical dosage forms and drug delivery systems, an interrelationship between these dosage forms/drug delivery systems and biopharmaceutical principals must be established to ensure clinical application of these dosage forms in patient care [2] . Drugs may be introduced into the body via some routes that involve an absorption phase such as oral, topical, intramuscular, subcutaneous, nasal, pulmonary and rectal. For intramuscular, and subcutaneous routes of administration, the absorption is uncomplicated and there is less variability in the absorption process and hence the bioavailability is often considered close to 100%. Drugs that are administered by intravascular route (Intravenous and intrarterial) do not involve an absorption step [3] . Assesment of bioavailability could be achieved from plasma data, urine data, acute clinical response and clinical trials [3] .
When a drug is administered into the body, it will distribute into the different organs and body compartments. Analysis of the drug kinetic in the body may be compartmental or noncompartmental. The former is used to describe the drug disposition (distribution and elimination) and the drug concentration in plasma and highly perfused organs assuming that changes in drug plasma concentration are equivalent with that in tissue concentration and the elimination process is achieved from central compartment. The later is used to identify certain pharmacokinetic parameters without deciding on a particular compartmental model. The basic calculations are based on the area under the plasma concentration versus times curve (zero moment) and the first moment curve (AUMC).
One-Compartment Open Model: Intravenous Bolus Administration
This model represents the simplest way to describe the process of drug distribution as well as elimination in the body. In this model, the body acts like a single, uniform unit in which the drug can enter or leave the body easily (i.e., the model is "open" for the drug movement).
For IV bolus administered drugs, the entire dose enters the bloodstream directly. This is followed by distribution of the drug through the circulatory system to all the tissues in the body. Concentration of the drug in various tissue organs or the process of drug distribution in the body will occur depending on the blood flow to the tissue, the molecular weight of the drug, the drug lipophilicity, plasma protein binding, and the binding affinity of the drug toward certain tissue.
Mostly, drugs are eliminated from the body either through the kidney and/or the liver following drug metabolism.
The first pharmacokinetic parameter that arises in this model is the apparent volume of distribution, V D , which is the volume in which the drug is distributed on it within the body, while the elimination rate constant, k, is the second pharmacokinetic parameter in this model, which governs the rate at which the drug concentration in the body declines over time.
A representative diagram that describes this model is illustrated below:
odel does not give information about the actual drug levels in the body tissues. However, This model does not give information about the actual drug levels in the body tissues. However, the model assumes that any changes in the plasma drug levels will always result in a relative change in tissue drug levels.
The general equation that describes this model is: 
Elimination Rate Constant
For most drugs, the process of drug elimination is a first-order rate process, i.e., the process is dependent on the amount or concentration of drug present, and the unit of the elimination rate constant k is time -1 (e.g., hr -1 or 1/hr).
Total removal or elimination of the parent drug from this compartment is effected by metabolism (biotransformation) and excretion. So, this constant represents the sum of these two processes:
A rate expression for the first-order elimination is:
Integration of the above equation gives the following expression: 
Example
The pK a of a weak acidic drug is 5. Calculate the U/P at urinary pH of 3, 5, and 7, respectively.
Solution
For acidic drug, U / 
Drug Clearance
As we mentioned for IV bolus administered drugs, Clearance or drug clearance is a pharmacokinetic term describing the process of drug elimination from the body without identifying the mechanism of this process. It refers to the volume of plasma fluid that is cleared of drug per unit time (volume approach, L/hr or ml/hr) or the amount of the drug eliminated from the body per unit time (mass approach, mg/min or mg/hr). It may also be considered as the fraction of the drug V D that is excreted by the kidney per unit of time (fraction approach).
Practically, drug clearance (body clearance, total body clearance, or Cl T ) may also be expressed based on the plasma drug concentration as the elimination rate of the drug divided by the plasma drug concentration. Since the drug elimination rate is a first-order process, so dD E /dt is equal to k D B or k C p V D .
Example
Calculate the elimination rate for penicillin if the plasma drug concentration is 2 µg/ml, assuming penicillin has a clearance of 15 ml/min. 
Physiologic/Organ Clearance
This term deals with any individual organ or tissue group involved in the process of drug removal from the body. If Q is the blood flow through this organ, Ca is the concentration of drug entering the organ (usually arterial drug concentration), Cv is the drug concentration leaving the organ (venous drug concentration), so the diagram that best describes this process will be:
Elimination Drug
Elimination Organ Figure 17 . Diagram that best describes the process of physiologic/Organ Clearance Accordingly, the physiologic/organ clearance may be described as the blood volume fraction which contains a specific drug that flows through the organ and is eliminated of this drug per unit time. Accordingly, clearance is considered as the product of the blood flow (Q) to the organ, and the extraction ratio (ER):
ER is the fraction of drug extracted by the organ as drug passes through and is equal Ca -C V divided by the entering drug concentration Ca, i.e., ER = (
It must be noted that clearance measurements using the physiologic approach require measurements of blood flow and extraction ratio to a specified organ or group of tissue, which is not so easy, and invasive techniques are needed to obtain these data.
Model-Independent Methods
These are noncompartment model approaches that help to determine certain pharmacokinetic parameters such as drug clearance and bioavailability (F). In these methods, no assumption for a specific compartment model is required to evaluate the data, which is the major advantage of these methods. In addition, no complicated methods are required to determine the studied pharmacokinetic parameters such as the volume of distribution and the elimination rate constant. These parameters can be calculated directly from the equation that best fits the plasma-drug-concentration time curve.
Clearance can be estimated directly from the plasma-time concentration curve by: Since AUC 0 α is calculated from the plasma-level time curve from 0 to infinity by the trapezoidal rule, no compartmental model is assumed.
In summary, clearances may be expressed mathematically as:
Renal Clearance
Renal clearance utilizes the same concept for the clearance or the drug clearance previously illustrated, except that the drug is cleared by the kidney and so the volume, mass, or fraction approaches are also applicable here. It could be expressed also as the urinary drug excretion rate (dDu/dt) divided by the plasma drug concentration:
For any drug cleared by the kidney, the rate of drug passing through the kidney must equal the rate of drug excreted in the urine.
where Cl R is renal clearance, C p is plasma drug concentration, Q u is the rate of urine flow, and C u is the urine drug concentration.
Excretion Mechanism (Comparison of Drug Excretion Methods)
Since the renal excretion is the urinary drug excretion rate (dDu/dt) divided by the plasma drug concentration, the expression could be rephrased to include the drug excretion mechanisms as follows: The excretion mechanism could be identified if the clearance value of the drug is compared to a well-recognized standard reference such as Inulin, which is a substance completely cleared through glomerular filtration only (clearance ratio). 
Example
If glomerular filtration at rate 125 ml/min is the sole elimination mechanism for gentamicin and kanamycin from the body, assuming gentamicin and kanamycin have V D of 10 and 20 L, respectively, is there a difference in the drug clearances for each drug based on the classic and physiologic approaches? If not, describe pharmacokinetic parameters that could be used to differentiate between the two drugs.
Solution
Since the two drugs are eliminated from the body by glomerular filtration only, the classic and physiologic approaches will be the same and equal 125 ml/min. So, there is an obvious difference between the elimination rate and half-life of the two drugs, although both have similar drug clearance.
Determination of Renal Clearance by Graphical Methods
It is possible to determine the renal clearance graphically by two methods:
1. If after administration of a drug, the drug excretion rate (dDu/dt) versus the plasma concentration (Cp) is plotted, the drug excretion rate is the slope of the curve, since Cl R = excretion rate/plasma concentration, but we must note that the slope will be large for drug that is excreted rapidly and will be of small value for drug that is excreted slowly through the kidney, i.e., the slope is smaller. 
Since the renal clearance
Rearranging and integration of the last equation will give:
If a graph were plotted of the cumulative drug excreted in the urine versus the area under the plasma-level time curve, renal clearance is the slope of the curve.
By plotting cumulative drug excreted in the urine from t 1 to t 2 , [D u ] t 2 t1 versus [AUC] t 2 t1 , an equation similar to that previously mentioned could be obtained, in which the slope is equal to the renal clearance: D u t 2 t 1 = Cl R AUC t 2 t 1 Figure 19 . A plot of the cumulative drug excreted in the urine versus the area under the plasma-level time curve . . .
Total body clearance (Cl T ) is equal to the sum of renal clearance and hepatic clearance:
Fraction of Drug Excreted
The fraction of drug excreted unchanged in the urine (f e ) is equal to the ratio of the total amount of unchanged drug excreted in the urine D α u , to the fraction of the dose absorbed, FD 0 :
It was found that (f e ) is also equal to ke/k: f e = D α u / F D 0 = k e / k Problem I) A single oral dose of antibiotic (500 mg) was given. The drug is 90% systemically available. The total amount of unchanged drug recovered in the urine was found to be 300 mg, and the total amount of metabolite recovered in the urine was 150 mg. The drug has an elimination half-life of 3.3 hr and its apparent volume of distribution is 1000 ml. Calculate the total body clearance, renal clearance, and nonrenal clearance. 
